Discontinuation report FRAGMIN
Report ID | 196174 |
Drug Identification Number | 02132664 |
Brand name | FRAGMIN |
Common or Proper name | FRAGMIN |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DALTEPARIN SODIUM |
Strength(s) | 10000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 10 x 1mL amp |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-02-13 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-02-14 | English | Compare |
v5 | 2024-02-13 | French | Compare |
v4 | 2024-02-13 | English | Compare |
v3 | 2024-02-13 | English | Compare |
v2 | 2023-06-22 | French | Compare |
v1 | 2023-06-22 | English | Compare |
Showing 1 to 6 of 6